Weiwei Wang
Impact in
- Cancer Research top 0.2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Thyroid Disorders and Treatments
Papers in
-
- RNA modifications and cancer 21
- Circular RNAs in diseases 20
- RNA Research and Splicing 9
- Ubiquitin and proteasome pathways 8
- Extracellular vesicles in disease 8
-
- Cancer-related molecular mechanisms research 32
- MicroRNA in disease regulation 27
- Co-authors
- Anquan Shang (38 shared papers)Weitang Yuan (6 shared papers)Quanbo Zhou (6 shared papers)Jinbo Liu (5 shared papers)Guixian Wang (5 shared papers)Chenzheng Gu (14 shared papers)Wenying Lu (17 shared papers)Zhongyan Shan (11 shared papers)
- Journals
- Artificial Cells Nanomedicine and Biotechnology (5 papers)Thyroid (5 papers)Oncotarget (4 papers)Molecular Cancer (4 papers)Journal of Oncology (4 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Weiwei Wang
138 papers receiving 6.5k citations
Weiwei Wang's Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 2.6k
- Endocrinology, Diabetes and Metabolism 863
- Molecular Biology 3.7k
- Oncology 697
- Immunology 521
Countries citing papers authored by Weiwei Wang
This map shows the geographic impact of Weiwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Wang more than expected).
Fields of papers citing papers by Weiwei Wang
This network shows the impact of papers produced by Weiwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Wang. The network helps show where Weiwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Exosomal circRNAs: biogenesis, effect and application in human diseases Hit paper breakdown → | 2019 | 513 |
| 2 | Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis Hit paper breakdown → | 2020 | 354 |
| 3 | 2019 | 330 | |
| 4 | 2009 | 322 | |
| 5 | 2014 | 239 | |
| 6 | 2016 | 223 | |
| 7 | 2014 | 202 | |
| 8 | 2020 | 188 | |
| 9 | 2018 | 177 | |
| 10 | 2019 | 175 | |
| 11 | 2013 | 171 | |
| 12 | 2019 | 161 | |
| 13 | 2020 | 147 | |
| 14 | 2021 | 126 | |
| 15 | 1999 | 120 | |
| 16 | 2021 | 113 | |
| 17 | 2017 | 110 | |
| 18 | 2020 | 103 | |
| 19 | 1998 | 98 | |
| 20 | 2016 | 76 |
About Weiwei Wang
Weiwei Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 143 papers that have together received 6.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (32 papers), MicroRNA in disease regulation (27 papers), RNA modifications and cancer (21 papers), Circular RNAs in diseases (20 papers), Thyroid Disorders and Treatments (10 papers), RNA Research and Splicing (9 papers), Ubiquitin and proteasome pathways (8 papers) and Extracellular vesicles in disease (8 papers). The work is most often cited by research in Cancer Research (2.6k citations), Endocrinology, Diabetes and Metabolism (863 citations), Molecular Biology (3.7k citations), Oncology (697 citations) and Immunology (521 citations). Weiwei Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Anquan Shang, Weitang Yuan, Quanbo Zhou, Jinbo Liu, Guixian Wang, Chenzheng Gu, Wenying Lu, Zhongyan Shan, Weiping Teng and Haijiang Wang. Their work appears in journals such as Artificial Cells Nanomedicine and Biotechnology, Thyroid, Oncotarget, Molecular Cancer and Journal of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.